Basit öğe kaydını göster

dc.contributor.authorMichel, Martin C.
dc.contributor.authorHeemann, Uwe
dc.contributor.authorde la Rosette, Jean J. M. C. H.
dc.date.accessioned2023-01-06T11:34:01Z
dc.date.available2023-01-06T11:34:01Z
dc.date.issued2022en_US
dc.identifier.citationMichel, M. C., Heemann, U. ve de la Rosette, J. J. M. C. H. (2022). Weak association between arterial hypertension and overactive bladder baseline symptoms and treatment responses. Frontiers in Pharmacology, 13. https://dx.doi.org/10.3389/fphar.2022.1081074en_US
dc.identifier.issn1663-9812
dc.identifier.urihttps://dx.doi.org/10.3389/fphar.2022.1081074
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10259
dc.description.abstractWhile animal studies have suggested an association between the presence of hypertension and the presence and/or severity of overactive bladder syndrome (OAB) symptoms, little clinical data is available. We have conducted a pre-specified secondary analysis of a non-interventional study involving 4450 OAB patients being treated with solifenacin to explore the existence of an association between OAB and hypertension using three parallel and overlapping definitions of hypertension to enhance robustness of analysis. Regardless of definition, patients with hypertension were older and had greater OAB symptom severity in univariate analyses. In multiple regression models including age as explanatory covariate, most relationships held up but effect sizes of concomitant hypertension on OAB severity were small (odds ratios <1.35 in all cases) and were deemed to be unlikely of clinical relevance. % Changes in symptom severity were somewhat smaller in univariate analysis, but effect sizes were small. We conclude that OAB and arterial hypertension are associated but effect sizes are too small to justify adaptation of clinical practice for OAB patients with concomitant hypertension.en_US
dc.description.sponsorshipAstellas Pharma GmbH ; Deutsche Forschungsgemeinschaften_US
dc.language.isoengen_US
dc.publisherFrontiers Media S.A.en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectOveractive Bladder Syndromeen_US
dc.subjectArterial Hypertensionen_US
dc.subjectNon-Interventional Studyen_US
dc.subjectPathophysiologyen_US
dc.subjectSolifenacinen_US
dc.subjectTreatmenten_US
dc.titleWeak association between arterial hypertension and overactive bladder baseline symptoms and treatment responsesen_US
dc.typearticleen_US
dc.relation.ispartofFrontiers in Pharmacologyen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalıen_US
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalıen_US
dc.authorid0000-0002-6308-1763en_US
dc.identifier.volume13en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.3389/fphar.2022.1081074en_US
dc.institutionauthorde la Rosette, Jean J. M. C. H.
dc.identifier.wosqualityQ1en_US
dc.identifier.wos000904318800001en_US
dc.identifier.scopus2-s2.0-85145070462en_US
dc.identifier.pmid36582525en_US
dc.identifier.scopusqualityQ1en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess